Cargando…
Combined treatment using adoptive cell therapy, extended pharmacokinetic IL-2, and tumor-specific antibodies leads to cures of established B16F10 tumors and extended in vivo T cell survival
Autores principales: | Opel, Cary F, Wittrup, K Dane |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3991202/ http://dx.doi.org/10.1186/2051-1426-1-S1-P26 |
Ejemplares similares
-
A Monograph on Ovarian Tumors: With an Extended View of Ovariotomy as a Means of Cure
por: Tweed, T. M.
Publicado: (1857) -
A Monograph on Ovarian Tumors: With an Extended View of Ovariotomy as a Means of Cure
por: Tweed, T. M.
Publicado: (1857) -
A Monograph on Ovarian Tumors: With an Extended View of Ovariotomy as a Means of Cure
por: Tweed, T. M.
Publicado: (1857) -
A Monograph on Ovarian Tumors; with an Extended View of Ovariotomy as a Means of Cure
por: Tweed, T. M.
Publicado: (1857) -
Pharmacokinetics of Coadministration of Guanfacine Extended Release and Methylphenidate Extended Release
por: Roesch, Benno, et al.
Publicado: (2013)